BRIAN NICHOLAS KELLY portrait
  • Adjunct Assistant Professor, Pathology
801-230-4151

Research Keywords

  • Detection & identification of performance enhancing drugs &/or precursors in biological specimens
  • Anti-Doping

Presentations

  • A Population Study of Urine Glycerol Concentrations in Elite Athletes Residing in North America Kelly BN, Madsen M, Sharpe K, Nair V, Eichner D Poster presentation at the 31st Manfred Donike Workshop on Dope Analysis, Cologne, Germany. Poster, Presented, 02/2013.
  • Circulating RNA as a Biomarker for Growth Hormone Doping Invited presentation at the 6th International Congress of the Growth Hormone and IGF-1 Research Society, Munich, Germany. Presentation, Presented, 10/2012.
  • Circulating RNA as a Biomarker for Growth Hormone Doping 2012 annual meeting of the Academy of Clinical Laboratory Physicians and Scientists, Milwaukee, Wisconsin. Awarded the Paul E. Strandjord Young Investigator Award . Presentation, Presented, 06/2012.
  • RNA-Biomarker Approaches for Detection of Recombinant Human Growth Hormone Abuse Invited oral presentation at the 10th Annual USADA Symposium on Anti-Doping Science held in London, England. Presentation, Presented, 10/2011.
  • Structure of HIV-1 CAN in Complex with CAP-1, an Assembly Inhibitor Invited oral presentation at the 15th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts . Presentation, Presented, 02/2008.

Languages

  • English, fluent.

Publications

  • Kelly BN, Haverstick DM, Lee JK, Thorner MO, Vance ML, Xin W, Bruns DE. Circulating microRNA as a biomarker of human growth hormone administration to patients. Drug Test Anal. 2013 Mar 12. doi: 10.1002/dta.1469. [Epub ahead of print] PubMed PMID: 23495241. Published, 03/2013.
  • Kelly BN, Haverstick DM, Vance ML, Thorner MO, Bruns DE. Quantification of growth hormone mRNA in blood. Clin Chim Acta. 2012 Dec 24;414:206-10. doi: 10.1016/j.cca.2012.09.011. Epub 2012 Sep 15. PubMed PMID: 22985689. Published, 09/2012.
  • Kelly BN, Haverstick DM, Bruns DE. Interference in a glucose dehydrogenase-based glucose meter revisited. Clin Chim Acta. 2012 Apr 11;413(7-8):829-30. doi: 10.1016/j.cca.2012.01.023. Epub 2012 Jan 25. PubMed PMID: 22301374. Published, 04/2012.
  • Kelly BN, Haverstick DM, Bruns DE. Interference in a glucose dehydrogenase-based glucose meter. Clin Chem. 2010 Jun;56(6):1038-40. doi: 10.1373/clinchem.2010.143453. Epub 2010 Apr 1. PubMed PMID: 20360123. Published, 06/2010.
  • Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell. 2009 Jun 26;137(7):1282-92. doi: 10.1016/j.cell.2009.04.063. Epub 2009 Jun 11. PubMed PMID: 19523676; PubMed Central PMCID: PMC2840706. Published, 06/2009.
  • Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol. 2007 Oct 19;373(2):355-66. Epub 2007 Aug 15. PubMed PMID: 17826792; PubMed Central PMCID: PMC2066180. Published, 10/2007.
  • Kelly BN, Howard BR, Wang H, Robinson H, Sundquist WI, Hill CP. Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry. 2006 Sep 26;45(38):11257-66. PubMed PMID: 16981686. Published, 09/2006.
  • Sundquist WI, Schubert HL, Kelly BN, Hill GC, Holton JM, Hill CP. Ubiquitin recognition by the human TSG101 protein. Mol Cell. 2004 Mar 26;13(6):783-9. PubMed PMID: 15053872. Published, 03/2004.